Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/99/5f/12/995f1267-3339-7058-b96e-ee21353fd31f/mza_9203593219483942390.jpg/600x600bb.jpg
The Bellcast
Bell Direct
85 episodes
1 week ago
In this episode of From the Helm, Grady Wulff sits down with Rural Funds Group (ASX:RFF) COO Tim Sheridan and General Manager of Investor Relations, Corporate Affairs & Sustainability, James Powell, to discuss Australia’s first ASX-listed agricultural REIT, its diversified portfolio of farmland, and growth strategy, including its expanding macadamia holdings. Tim and James share insights into RFF’s portfolio composition, market outlook, and how the company is leveraging technology and sus...
Show more...
Investing
Business
RSS
All content for The Bellcast is the property of Bell Direct and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of From the Helm, Grady Wulff sits down with Rural Funds Group (ASX:RFF) COO Tim Sheridan and General Manager of Investor Relations, Corporate Affairs & Sustainability, James Powell, to discuss Australia’s first ASX-listed agricultural REIT, its diversified portfolio of farmland, and growth strategy, including its expanding macadamia holdings. Tim and James share insights into RFF’s portfolio composition, market outlook, and how the company is leveraging technology and sus...
Show more...
Investing
Business
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/99/5f/12/995f1267-3339-7058-b96e-ee21353fd31f/mza_9203593219483942390.jpg/600x600bb.jpg
From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD
The Bellcast
11 minutes
1 month ago
From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD
Join Bell Financial Group's Senior Market Analyst Grady Wulff as she sat down with Dr. Liz Dallimore, CEO & MD of Argenica Therapeutics (ASX:AGN) to discuss the company's lead drug candidate ARG-007, and its pathway to commercialisation to become the world's first neuroprotective drug for the protection of brain cells post stroke or catastrophic brain injury. In this interview, Liz covers: • (0:40) an overview of Argenica Therapeutics (ASX:AGN) • (1:28) details on ARG-007, inc...
The Bellcast
In this episode of From the Helm, Grady Wulff sits down with Rural Funds Group (ASX:RFF) COO Tim Sheridan and General Manager of Investor Relations, Corporate Affairs & Sustainability, James Powell, to discuss Australia’s first ASX-listed agricultural REIT, its diversified portfolio of farmland, and growth strategy, including its expanding macadamia holdings. Tim and James share insights into RFF’s portfolio composition, market outlook, and how the company is leveraging technology and sus...